Cite

HARVARD Citation

    Murthy, S. et al. (n.d.). Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis. Inflammatory bowel diseases. 21 (9), p. . [Online]. 
  
Back to record